AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 1053442 — intervention group
Group type: EXPERIMENTAL
Intervention: RAST
Number of subjects: 141
Study 1053442 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal test
Number of subjects: 141
Study 1053442 — intervention group
Group type: EXPERIMENTAL
Intervention: History of hay fever
Number of subjects: 141
Study 30540355 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 13885
Study 30540355 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 13885
Study 30540355 — intervention group
Group type: EXPERIMENTAL
Intervention: Postrandomization MI
Number of subjects: 13885
Study 28838589 — intervention group
Group type: EXPERIMENTAL
Intervention: Early mobilization (EM) protocol consisting of mobilization from bed in the first 3 days after surgery in the morning and evening.
Number of subjects: 100
Study 28838589 — intervention group
Group type: COMPARATOR
Intervention: Control group mobilized from bed on the third postoperative day according to hospital routine.
Number of subjects: 100
Study 26372934 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenatal Motivational Interviewing (MI)
Number of subjects: 400
Study 26372934 — intervention group
Group type: COMPARATOR
Intervention: Prenatal Health Education (HE)
Number of subjects: 400
Study 26372934 — intervention group
Group type: EXPERIMENTAL
Intervention: Postpartum Motivational Interviewing (MI)
Number of subjects: 400
Study 26372934 — intervention group
Group type: COMPARATOR
Intervention: Postpartum Health Education (HE)
Number of subjects: 400
Study 23384381 — intervention group
Group type: EXPERIMENTAL
Intervention: Beer (alcohol condition)
Number of subjects: 40
Study 23384381 — intervention group
Group type: COMPARATOR
Intervention: Water (alcohol-free condition)
Number of subjects: 40
Study 23384381 — intervention group
Group type: EXPERIMENTAL
Intervention: BAC estimates (calculated formula)
Number of subjects: 40
Study 23384381 — intervention group
Group type: EXPERIMENTAL
Intervention: BAC estimates (breath alcohol device)
Number of subjects: 40
Study 23384381 — intervention group
Group type: EXPERIMENTAL
Intervention: Gender (female participants)
Number of subjects: 40
Study 20535606 — intervention group
Group type: EXPERIMENTAL
Intervention: Bazedoxifene 20 mg
Number of subjects: 7492
Study 20535606 — intervention group
Group type: EXPERIMENTAL
Intervention: Bazedoxifene 40 mg
Number of subjects: 7492
Study 20535606 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7492
Study 18723413 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic positioning device (MP) assisted colonoscopy
Number of subjects: 38
Study 18723413 — intervention group
Group type: COMPARATOR
Intervention: Standard colonoscopy (SC)
Number of subjects: 38
Study 17106318 — intervention group
Group type: EXPERIMENTAL
Intervention: Betaxolol hydrochloride
Number of subjects: 0
Study 17106318 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended-release metoprolol tartrate
Number of subjects: 0
Study 12713450 — intervention group
Group type: EXPERIMENTAL
Intervention: CEE + MPA
Number of subjects: 105
Study 12713450 — intervention group
Group type: EXPERIMENTAL
Intervention: Tibolone
Number of subjects: 105
Study 12713450 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 105
Study 10878702 — intervention group
Group type: EXPERIMENTAL
Intervention: Postprandial changes in glucose, insulin, triglyceride, and non‐esterified fatty acids (NEFA) after consuming a test meal containing 45% fat.
Number of subjects: 40
Study 8933487 — intervention group
Group type: EXPERIMENTAL
Intervention: 5.5% CHO-electrolyte solution (E)
Number of subjects: 11
Study 8933487 — intervention group
Group type: EXPERIMENTAL
Intervention: 6.9% CHO-electrolyte solution (L)
Number of subjects: 11
Study 8933487 — intervention group
Group type: COMPARATOR
Intervention: Water (W)
Number of subjects: 11
Study 1559512 — intervention group
Group type: EXPERIMENTAL
Intervention: MUFA diet (olive oil)
Number of subjects: 11
Study 1559512 — intervention group
Group type: COMPARATOR
Intervention: SAFA diet (butter)
Number of subjects: 11
Study 3158183 — intervention group
Group type: EXPERIMENTAL
Intervention: Nafazatrom (1.2 gm)
Number of subjects: 20
Study 3158183 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 30643620 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based videoconference meeting via Google Hangouts
Number of subjects: 133
Study 30643620 — intervention group
Group type: COMPARATOR
Intervention: In-person meeting
Number of subjects: 133
Study 27702847 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary vein isolation (PVI) alone
Number of subjects: 35
Study 26512712 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate intervention (home-based lifestyle counseling)
Number of subjects: 641
Study 26512712 — intervention group
Group type: COMPARATOR
Intervention: 12-month-wait-listed control arm
Number of subjects: 641
Study 21114603 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 50 mg with pioglitazone 45 mg
Number of subjects: 60
Study 21114603 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 20 mg with metformin 1000 mg
Number of subjects: 60
Study 21114603 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 20 mg with glimepiride 4 mg
Number of subjects: 60
Study 21114603 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 20 mg with sitagliptin 100 mg
Number of subjects: 60
Study 19236394 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized literacy instruction
Number of subjects: 461
Study 19236394 — intervention group
Group type: COMPARATOR
Intervention: Comparison instruction
Number of subjects: 461
Study 17096386 — intervention group
Group type: EXPERIMENTAL
Intervention: CCAP intervention (combined cognitive‐behavioral therapy and pharmacotherapy)
Number of subjects: 232
Study 17096386 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 232
Study 15082132 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin A (Dysport) 500 mouse units
Number of subjects: 112
Study 15082132 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 112
Study 11464259 — intervention group
Group type: COMPARATOR
Intervention: Hypertensive individuals (dietary sodium intake)
Number of subjects: 2068
Study 11464259 — intervention group
Group type: COMPARATOR
Intervention: Hypertensive women (dietary sodium-to-potassium ratio)
Number of subjects: 2068
Study 11464259 — intervention group
Group type: EXPERIMENTAL
Intervention: Age, body mass index, overweight, family history of hypertension
Number of subjects: 2068
Study 11464259 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary sodium intake and dietary sodium-to-potassium ratio
Number of subjects: 2068
Study 11464259 — intervention group
Group type: EXPERIMENTAL
Intervention: Education level in women
Number of subjects: 2068
Study 11464259 — intervention group
Group type: EXPERIMENTAL
Intervention: Commuting physical activity in men
Number of subjects: 2068
Study 9820380 — intervention group
Group type: EXPERIMENTAL
Intervention: PyloriTek test in cases without eradication therapy
Number of subjects: 163
Study 9820380 — intervention group
Group type: EXPERIMENTAL
Intervention: PyloriTek test in cases with eradication therapy
Number of subjects: 163
Study 9820380 — intervention group
Group type: EXPERIMENTAL
Intervention: PyloriTek test used more than 4 months after eradication therapy
Number of subjects: 163
Study 8085448 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal continuous positive airway pressure (N‐CPAP)
Number of subjects: 15
Study 8085448 — intervention group
Group type: COMPARATOR
Intervention: Mechanical ventilation
Number of subjects: 15
Study 8085448 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (N‐CPAP and ventilator)
Number of subjects: 15
Study 2627407 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 micrograms/kg butorphanol
Number of subjects: 60
Study 2627407 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 micrograms/kg butorphanol
Number of subjects: 60
Study 2627407 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 micrograms/kg fentanyl
Number of subjects: 60
Study 9636 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurazepam 15 mg
Number of subjects: 0
Study 9636 — intervention group
Group type: COMPARATOR
Intervention: Amylobarbitone sodium 100 mg
Number of subjects: 0
Study 31119709 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based education group
Number of subjects: 75
Study 31119709 — intervention group
Group type: EXPERIMENTAL
Intervention: Brochure group
Number of subjects: 75
Study 31119709 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 75
Study 31583252 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 IU of vitamin D3 daily for 30 consecutive months
Number of subjects: 0
Study 31583252 — intervention group
Group type: EXPERIMENTAL
Intervention: CYP27B1 (rs10877012) G/T genotype
Number of subjects: 0
Study 28353655 — intervention group
Group type: EXPERIMENTAL
Intervention: High Meat Diet (HMD)
Number of subjects: 51
Study 28353655 — intervention group
Group type: COMPARATOR
Intervention: High Whole Grain Diet (HWD)
Number of subjects: 51
Study 25045035 — intervention group
Group type: EXPERIMENTAL
Intervention: Playing a turned-on musical keyboard (audio feedback present)
Number of subjects: 19
Study 25045035 — intervention group
Group type: COMPARATOR
Intervention: Performing exercises on a turned-off musical keyboard (audio feedback absent)
Number of subjects: 19
Study 23217660 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirtazapine
Number of subjects: 36
Study 23217660 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 21535876 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based intervention for preventing and managing illnesses related to HIV, TB, alcohol use, and malnutrition in pregnant mothers and their infants.
Number of subjects: 1062
Study 20024744 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI) sessions by peer outreach workers (POW)
Number of subjects: 87
Study 20024744 — intervention group
Group type: COMPARATOR
Intervention: Motivational Interviewing (MI) sessions by masters level staff (MLS)
Number of subjects: 87
Study 16446322 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin 80 mg/m2 intravenously on day 1
Number of subjects: 250
Study 16446322 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin 80 mg/m2 intravenously on day 1 with raltitrexed 3 mg/m2
Number of subjects: 250
Study 15471393 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 73
Study 11273920 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 23
Study 11273920 — intervention group
Group type: COMPARATOR
Intervention: Halothane
Number of subjects: 23
Study 9435365 — intervention group
Group type: EXPERIMENTAL
Intervention: Group III (obese with Central Obesity Predominance, N = 23)
Number of subjects: 31
Study 8300711 — intervention group
Group type: EXPERIMENTAL
Intervention: Below-knee elastic stockings
Number of subjects: 38
Study 8300711 — intervention group
Group type: COMPARATOR
Intervention: Control group (no elastic compression)
Number of subjects: 38
Study 6410104 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast neutron therapy (average energy, 6 MeV)
Number of subjects: 49
Study 6410104 — intervention group
Group type: COMPARATOR
Intervention: Linac x-ray therapy (10 MV)
Number of subjects: 49
Study 6410104 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast neutron therapy
Number of subjects: 49
Study 6410104 — intervention group
Group type: COMPARATOR
Intervention: Linac x-ray therapy
Number of subjects: 49
Study 6410104 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast neutron therapy and Linac x-ray therapy
Number of subjects: 49
Study 31217549 — intervention group
Group type: EXPERIMENTAL
Intervention: Good sleep quality
Number of subjects: 3832
Study 28280333 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture plus artificial tears (AC + AT)
Number of subjects: 28
Study 28280333 — intervention group
Group type: COMPARATOR
Intervention: Artificial tears (AT) only
Number of subjects: 28
Study 26204126 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal ring
Number of subjects: 50
Study 26204126 — intervention group
Group type: COMPARATOR
Intervention: COC pills
Number of subjects: 50
Study 23986022 — intervention group
Group type: EXPERIMENTAL
Intervention: KidScents™ toothpaste
Number of subjects: 20
Study 23986022 — intervention group
Group type: EXPERIMENTAL
Intervention: Browning B& B™ toothpaste
Number of subjects: 20
Study 23986022 — intervention group
Group type: EXPERIMENTAL
Intervention: Wysong Probiodent™ toothpaste
Number of subjects: 20
Study 23986022 — intervention group
Group type: COMPARATOR
Intervention: Water (positive control)
Number of subjects: 20
Study 22453191 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg intranasal midazolam
Number of subjects: 12
Study 22453191 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 mg intranasal midazolam
Number of subjects: 12
Study 22453191 — intervention group
Group type: COMPARATOR
Intervention: 5 mg intravenous midazolam
Number of subjects: 12
Study 19236375 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal desmopressin (IN‐DDAVP)
Number of subjects: 116
Study 19236375 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TA)
Number of subjects: 116
Study 19236375 — intervention group
Group type: COMPARATOR
Intervention: Comparison of TA to IN‐DDAVP
Number of subjects: 116
Study 19236375 — intervention group
Group type: EXPERIMENTAL
Intervention: Both IN‐DDAVP and TA
Number of subjects: 116
Study 17577015 — intervention group
Group type: EXPERIMENTAL
Intervention: Boost dose of 16 Gy (2,661 patients)
Number of subjects: 5318
Study 17577015 — intervention group
Group type: COMPARATOR
Intervention: No boost dose (2,657 patients)
Number of subjects: 5318
Study 17577015 — intervention group
Group type: EXPERIMENTAL
Intervention: Both arms (boost and no boost)
Number of subjects: 5318
Study 16796540 — intervention group
Group type: EXPERIMENTAL
Intervention: AeroChamber Max VHC (out-of-the-package)
Number of subjects: 0
Study 16796540 — intervention group
Group type: EXPERIMENTAL
Intervention: AeroChamber Max VHC (pre-washed/rinsed)
Number of subjects: 0
Study 16796540 — intervention group
Group type: EXPERIMENTAL
Intervention: ProChamber VHC (pre-washed)
Number of subjects: 0
Study 16796540 — intervention group
Group type: EXPERIMENTAL
Intervention: OptiChamber Advantage VHC (pre-washed)
Number of subjects: 0
Study 15011204 — intervention group
Group type: COMPARATOR
Intervention: Standard Epley maneuver
Number of subjects: 0
Study 15011204 — intervention group
Group type: EXPERIMENTAL
Intervention: Augmented Epley (additional 45 degrees head rotation)
Number of subjects: 0
Study 15011204 — intervention group
Group type: EXPERIMENTAL
Intervention: Home Instruction (instructions about sleeping position)
Number of subjects: 0
Study 10368838 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT)
Number of subjects: 100
Study 10368838 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 10368838 — intervention group
Group type: EXPERIMENTAL
Intervention: HRT
Number of subjects: 100
Study 8933789 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI (T2-weighted SE MRI)
Number of subjects: 152
Study 8933789 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphologic assessment
Number of subjects: 152
Study 1896820 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine
Number of subjects: 115
Study 1896820 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 115
Study 1896820 — intervention group
Group type: EXPERIMENTAL
Intervention: MCO responders
Number of subjects: 115
Study 6336941 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine
Number of subjects: 20
Study 6336941 — intervention group
Group type: COMPARATOR
Intervention: Pentazocine
Number of subjects: 20
Study 31394283 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotics plus albumin (study group)
Number of subjects: 118
Study 31394283 — intervention group
Group type: COMPARATOR
Intervention: Antibiotics alone (control group)
Number of subjects: 118
Study 30828917 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 1997
Study 30828917 — intervention group
Group type: COMPARATOR
Intervention: Oral antidiabetic drugs (OADs)
Number of subjects: 1997
Study 28459406 — intervention group
Group type: EXPERIMENTAL
Intervention: MPRDT-FOB
Number of subjects: 240
Study 28459406 — intervention group
Group type: COMPARATOR
Intervention: PDT
Number of subjects: 240
Study 28459406 — intervention group
Group type: COMPARATOR
Intervention: MPDT
Number of subjects: 240
Study 28459406 — intervention group
Group type: COMPARATOR
Intervention: PDT-FOB
Number of subjects: 240
Study 24811050 — intervention group
Group type: EXPERIMENTAL
Intervention: Micropulse cyclophotocoagulation
Number of subjects: 48
Study 24811050 — intervention group
Group type: COMPARATOR
Intervention: Continuous wave cyclophotocoagulation
Number of subjects: 48
Study 23833868 — intervention group
Group type: EXPERIMENTAL
Intervention: Loss-framed message in white text on a red background
Number of subjects: 180
Study 23833868 — intervention group
Group type: COMPARATOR
Intervention: Gain-framed message
Number of subjects: 180
Study 21696072 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-coronary bone marrow mononuclear cell (BMC) transplantation
Number of subjects: 23
Study 21696072 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 23
Study 19536417 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation (30 mg/day)
Number of subjects: 61
Study 19536417 — intervention group
Group type: COMPARATOR
Intervention: Control (no zinc supplementation)
Number of subjects: 61
Study 17047540 — intervention group
Group type: EXPERIMENTAL
Intervention: BMP/compression resistant matrix
Number of subjects: 98
Study 17047540 — intervention group
Group type: COMPARATOR
Intervention: Iliac crest bone graft
Number of subjects: 98
Study 12718221 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-stage rehabilitation (outpatient clinic-hospital-sanatorium) for 9 months
Number of subjects: 0
Study 12718221 — intervention group
Group type: COMPARATOR
Intervention: Rehabilitation only in outpatient clinic
Number of subjects: 0
Study 10671903 — intervention group
Group type: EXPERIMENTAL
Intervention: MDMA 50 mg
Number of subjects: 14
Study 10671903 — intervention group
Group type: EXPERIMENTAL
Intervention: MDMA 100 mg
Number of subjects: 14
Study 10671903 — intervention group
Group type: EXPERIMENTAL
Intervention: MDMA 150 mg
Number of subjects: 14
Study 10671903 — intervention group
Group type: EXPERIMENTAL
Intervention: MDMA 75 mg
Number of subjects: 14
Study 10671903 — intervention group
Group type: EXPERIMENTAL
Intervention: MDMA 125 mg
Number of subjects: 14
Study 10671903 — intervention group
Group type: EXPERIMENTAL
Intervention: MDMA (all doses tested)
Number of subjects: 14
Study 10671903 — intervention group
Group type: EXPERIMENTAL
Intervention: MDMA (general conclusion)
Number of subjects: 14
Study 9348549 — intervention group
Group type: EXPERIMENTAL
Intervention: m-chlorophenylpiperazine (mCPP) 0.1 mg/kg during TRP depletion
Number of subjects: 22
Study 9348549 — intervention group
Group type: COMPARATOR
Intervention: m-chlorophenylpiperazine (mCPP) 0.1 mg/kg during sham depletion
Number of subjects: 22
Study 8250285 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical ligation
Number of subjects: 71
Study 8250285 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiographic embolization
Number of subjects: 71
Study 4083102 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to smoking cues
Number of subjects: 48
Study 4083102 — intervention group
Group type: COMPARATOR
Intervention: Nonexposure to smoking cues
Number of subjects: 48
Study 28686073 — intervention group
Group type: EXPERIMENTAL
Intervention: 180 min of normobaric poikilocapnic hypoxia (capillary oxygen saturation 70-75%)
Number of subjects: 15
Study 28686073 — intervention group
Group type: COMPARATOR
Intervention: Sham (normoxia)
Number of subjects: 15
Study 29352713 — intervention group
Group type: EXPERIMENTAL
Intervention: Sipuleucel-T immunotherapy
Number of subjects: 94
Study 26661520 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre‐wounded sites
Number of subjects: 10
Study 26661520 — intervention group
Group type: COMPARATOR
Intervention: Routine graft sites
Number of subjects: 10
Study 26661520 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine and pre‐wounded sites
Number of subjects: 10
Study 24675915 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency TENS (HFT) (100 Hz; 100 µs)
Number of subjects: 33
Study 24675915 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-frequency TENS (LFT) (5 Hz; 100 µs)
Number of subjects: 33
Study 24675915 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PT)
Number of subjects: 33
Study 22648716 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose solution with alcohol (21 g alcohol, 25 g carbohydrates)
Number of subjects: 10
Study 22648716 — intervention group
Group type: EXPERIMENTAL
Intervention: Beer (4.5% alcohol by volume, 25 g carbohydrates)
Number of subjects: 10
Study 22648716 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonalcoholic beer (25 g carbohydrates)
Number of subjects: 10
Study 22648716 — intervention group
Group type: COMPARATOR
Intervention: Reference glucose solution (25 g carbohydrates)
Number of subjects: 10
Study 20300014 — intervention group
Group type: EXPERIMENTAL
Intervention: High branched chain amino acids (BCAA)
Number of subjects: 8
Study 20300014 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 17098331 — intervention group
Group type: EXPERIMENTAL
Intervention: Levodopa (100mg) plus carbidopa (25mg) during training
Number of subjects: 0
Study 17098331 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 15972322 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral vitamin C supplementation (250 mg three times per week for 2 months)
Number of subjects: 33
Study 11253577 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported adherence to PEFR monitoring
Number of subjects: 42
Study 11253577 — intervention group
Group type: COMPARATOR
Intervention: Electronically monitored adherence to PEFR monitoring
Number of subjects: 42
Study 9731680 — intervention group
Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastric bypass with 75 cm limb for BMI ≤ 51 kg/m2 (n = 20)
Number of subjects: 60
Study 9731680 — intervention group
Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastric bypass with 150 cm limb for BMI ≤ 51 kg/m2 (n = 16)
Number of subjects: 60
Study 9731680 — intervention group
Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastric bypass with 150 cm limb for BMI ≥ 51 kg/m2 (n = 18)
Number of subjects: 60